Gabapentin Enacarbil
Back to searchMolecule Structure
Scientific Name
Gabapentin Enacarbil
Description of the Drug
Gabapentin enacarbil is a gabapentin prodrug used to treat Restless Legs Syndrome (RLS) and postherpetic neuralgia (PHN).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08872
http://www.drugbank.ca/drugs/DB08872
Brand Name(s)
Horizant
Company Owner(s)
Azurity Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Voltage-gated calcium channel | PROTEIN COMPLEX GROUP | MODULATOR | CHEMBL2363032 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL25455 | |
| Human Metabolome Database | HMDB0252567 | |
| DrugBank | DB08872 | |
| PubChem: Thomson Pharma | 14850951 | |
| PubChem | 9883933 | |
| Nikkaji | J3.209.908D | |
| DrugCentral | 4177 | |
| ChemicalBook | CB01011737 | |
| Guide to Pharmacology | 7560 | |
| rxnorm | HORIZANT | GABAPENTIN ENACARBIL |
| PubChem: Drugs of the Future | 22395865 | |
| ChEBI | 68840 |
